Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells
/in Dendritic Cells, Exosome, Glioblastoma, International Publications /von 2019-08-09 / J Extracell Vesicles 2019;8(1):1648995Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2019-06-17 / J Clin Oncol 37, 2019 (suppl; abstr e13526)A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
/in Dendritic Cells, Glioblastoma, International Publications /von 2019-04-15 / Cancers (Basel) 2019 Apr;11(4)Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2019-04-01 / Anticancer Res 2019 Apr;39(4):2043-2051An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2019-01-07 / Int. J. Cancer 2019 Jun;144(11):2867-2879Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2019-01-01 / Klin Onkol 2019;32(1):70-74Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study
/in Glioblastoma, Hyperthermia, International Publications /von 2018-12-22 / Integr Cancer Ther 2019 Jan-Dec;18:1534735418812691Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-12-05 / Acta Neuropathol Commun 2018 12;6(1):135The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-11-12 / Cancers (Basel) 2018 Nov;10(11)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de